OpenVSafe by OpenVAERS
Search V-safe

3WW-14956-10214

2 vaccinations 6 coded responses 20 check-ins 6 free-text entries 1 call case
Sex
Female
Age at first dose
46-50
ZIP prefix
840 / UT
Registered
2021-01-01
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2020-12-28
    Dose 1 — Moderna
  2. 2021-01-01
    Registered in v-safe
  3. 2021-01-01
    Survey response — days 1–6 daily, dose 1
    MedDRA: Myasthenia gravis, Ophthalmoplegia, Pre-existing disease, Vision blurred — Feeling: Good · Site: Pain · Fatigue or tiredness
    Free text: Worsening of Myasthenia symptoms with weak eye muscles and blurry vision
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  4. 2021-01-02
    Survey response — days 1–6 daily, dose 1
    MedDRA: Condition aggravated, Pre-existing disease — Feeling: Good
    Free text: Myasthenia symptoms were slightly pronounced from baseline but controlled with Mestinon.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  5. 2021-01-03
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  6. 2021-01-04
    Health check-in — day 7, dose 1
    Feeling: Good · None
    Adult check-in
  7. 2021-01-18
    Health check-in — day 21, dose 1
    Feeling: Good
    Adult check-in
  8. 2021-01-25
    Dose 2 — Moderna
  9. 2021-01-25
    Health check-in — day 0, dose 2
    Feeling: Good · Site: Pain · None
    Adult check-in
  10. 2021-01-26
    Health check-in — days 1–6 daily, dose 2
    Feeling: Poor · Site: Pain · Fever · Muscle or body aches, Nausea · Be unable to work
    Adult check-in
  11. 2021-01-28
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  12. 2021-01-29
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  13. 2021-01-30
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  14. 2021-01-31
    Survey response — days 1–6 daily, dose 2
    MedDRA: Unevaluable event — Feeling: Good · Headache, Fatigue or tiredness
    Free text: I don't know if related or not.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  15. 2021-02-01
    Survey response — day 7, dose 2
    MedDRA: Unevaluable event — Feeling: Good
    Free text: I do have to temporarily go back on Mestinon.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  16. 2021-02-08
    Health check-in — day 14, dose 2
    Feeling: Fair
    Adult check-in
  17. 2021-02-15
    Health check-in — day 21, dose 2
    Feeling: Fair
    Adult check-in
  18. 2021-02-22
    Survey response — day 28, dose 2
    MedDRA: Diplopia, Muscular weakness, Myasthenia gravis, Pre-existing disease — Feeling: Poor · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation
    Free text: Worsened my Myasthenia Gravis control: muscle weakness and double vision. I hope I return to my baseline.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  19. 2021-02-22
    Report sent to call center — day 28, dose 2
    Get care from a doctor or other healthcare professional
    1 call case(s)
  20. 2021-03-03
    Health check-in — day 35, dose 2
    Feeling: Fair
    Adult check-in
  21. 2021-03-09
    Health check-in — day 42, dose 2
    Feeling: Good
    Adult check-in
  22. 2021-04-26
    Health check-in — 3 months, dose 2
    Feeling: Fair
    Adult check-in
  23. 2021-07-26
    Health check-in — 6 months, dose 2
    Feeling: Good
    Adult check-in
  24. 2021-08-16
  25. 2022-01-26
    Survey response — 12 months, dose 2
    MedDRA: SARS-CoV-2 test positive — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities
    Free text: I tested positive for Covid today after having 3 full strength Moderna vaccinations.
    MedDRA releases: 2024-11 · check-in free text available

Vaccinations

DoseDateManufacturerCo-administered
12020-12-28Moderna
22021-01-25Moderna

Call center

1 call center case

1 unsuccessful

1 wait over 3 months for a first call

See the call center timeline

Free text

Release 1 — days 1–6 daily, dose 1

2021-01-01

Systemic reaction (other): Worsening of Myasthenia symptoms with weak eye muscles and blurry vision

2021-01-02

Systemic reaction (other): Myasthenia symptoms were slightly pronounced from baseline but controlled with Mestinon.

Release 3 — days 1–6 daily, dose 2

2021-01-31

Systemic reaction (other): I don't know if related or not.

Release 3 — day 7, dose 2

2021-02-01

Systemic reaction (other): I do have to temporarily go back on Mestinon.

Release 4 — day 28, dose 2

2021-02-22

Symptoms: Worsened my Myasthenia Gravis control: muscle weakness and double vision. I hope I return to my baseline.

Release 11 — 12 months, dose 2

2022-01-26

Symptoms: I tested positive for Covid today after having 3 full strength Moderna vaccinations.

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDDiplopia ✓ ✓ ✓
SDMuscular weakness ✓ ✓ ✓
SDMyasthenia gravis ✓ ✓ ✓
SDPre-existing disease ✓ ✓ ✓
SDSARS-CoV-2 test positive · · ✓
SROCondition aggravated ✓ ✓ ✓
SROMyasthenia gravis ✓ ✓ ✓
SROOphthalmoplegia ✓ ✓ ✓
SROPre-existing disease ✓ ✓ ✓
SROUnevaluable event ✓ ✓ ✓
SROVision blurred ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release

Loading…